Last Updated: June 22, 2026

CLOMIPRAMINE Drug Patent Profile

Name: CLOMIPRAMINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Clomipramine patents expire, and what generic alternatives are available?

Clomipramine is a drug marketed by Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Aurobindo Pharma, Chartwell Rx, Ixora Lifescience, Jubilant Cadista, Lupin, Mankind Pharma, Micro Labs, Pharmobedient, Rk Pharma, Sandoz, Taro, Teva, Tp Anda Holdings, Unique, Watson Labs, and Zydus Pharms. and is included in twenty-one NDAs.

The generic ingredient in CLOMIPRAMINE is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Clomipramine

A generic version of CLOMIPRAMINE was approved as clomipramine hydrochloride by CHARTWELL RX on March 29^th, 1996.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CLOMIPRAMINE?
What are the global sales for CLOMIPRAMINE?
What is Average Wholesale Price for CLOMIPRAMINE?

Summary for CLOMIPRAMINE

US Patents:	0
Applicants:	19
NDAs:	21
Drug Prices:	Drug price information for CLOMIPRAMINE
DailyMed Link:	CLOMIPRAMINE at DailyMed

Drug patent expirations by year for CLOMIPRAMINE

US Patents and Regulatory Information for CLOMIPRAMINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	074694-002	Dec 31, 1996	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Pharmobedient	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	074947-002	Apr 30, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Tp Anda Holdings	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	210653-001	Apr 3, 2020	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	074751-003	Sep 30, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for CLOMIPRAMINE

Nct04512345 clomipramine selective serotonin reuptake inhibitor?
Clomipramine generic name?
Clomipramine hydrochloride manufacturers?
Clomipramine vs sertraline?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.